Isolation and identification of E. cowanii from powdered infant formula in NICU and determination of antimicrobial susceptibility of isolates

Iranian Journal of Pediatrics

Volumn 24, Issue 3, 2014, Pages 261-266

  Mardaneh, Jalal ^a,b   Soltan Dallal, Mohammad Mehdi ^b,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial susceptibility; E. Cowanii; Neonatal intensive care unit; Powdered infant formula milk

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; AZTREONAM; CARBENICILLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; MEZLOCILLIN; MINOCYCLINE; MOXIFLOXACIN; NALIDIXIC ACID; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; TETRACYCLINE; TICARCILLIN; TIGECYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL MILK; BACTERIUM CONTAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CROSS-SECTIONAL STUDY; DISK DIFFUSION; ENTEROBACTER; ENTEROBACTER COWANII; FOOD ANALYSIS; FOOD CONTAMINATION; IRAN; MICROBIOLOGICAL EXAMINATION; NEWBORN INTENSIVE CARE; NONHUMAN;

EID: 84901498246     PISSN: 20082142     EISSN: 20082150     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Morand PC, Billoet A, Rottman M et al. Specific distribution within the Enterobacter cloacae complex of strains isolated from infected orthopedic implants. J Clin Microbiol 2009;47(8):2489-2495.
2. Hormaeche E, Edwards PR. A proposed genus Enterobacter. Int Bull Bacteriol Nomencl Taxon 1960;10:71-74.
3. Brady CL, Venter SN, Cleenwerck I, et al. Isolation of Enterobacter cowanii from Eucalyptus showing symptoms of bacterial blight and dieback in Uruguay. Lett Appl Microbio l 2009;49(4):461-465.
4. Inoue K, Sugiyama K, Kosako Y, et al. Enterobacter cowanii sp. nov., a new species of the family Enterobacteriaceae. Curr Microbiol 2000;41(6):417-420.
5. Wetzel K, Lee J, Lee CS, et al. Comparison of microbial diversity of edible flowers and basil grown with organic versus conventional methods. Can J Microbiol 2010;56(11):943-951.
6. Furtado GQ, Guimarães LMS, Lisboa DO, et al. First report of Enterobacter cowanii causing bacterial spot on Mabea fistulifera, a native forest species in Brazil. Plant Disease 2012;96(10):1576.
7. Brady C, Cleenwerck I, Venter S, et al. Phylogeny and identification of Pantoea species associated with plants, humans and the natural environment based on multilocus sequence analysis (MLSA). Syst Appl Microbiol 2008; 31(6-8):447-460.
8. Karambin M, Zarkesh M. Entrobacter, the most common pathogen of neonatal septicemia in Rasht, Iran. Iran J Pediatr 2011;21(1):83-87.
9. Mussi-Pinhata MM, do Nascimento SD. Neonatal nosocomial infections. J Pediatr (Rio J) 2001; 77(Suppl 1):S81-S96.
10. Hewitt KM, Mannino FL, Gonzalez A, et al. Bacterial diversity in two neonatal intensive care units (NICUs). PLoS One 2013;8(1):e54703.
11. Sarookhani MR, Ayazi P, Alizadeh S, et al. Comparison of 16S RDNA-PCR amplification and culture of cerebrospinal fluid for diagnosis of bacterial meningitis. Iran J Pediatr 2010;20(4):471-475.
12. Lund BM, O'Brien SJ. The occurrence and prevention of foodborne disease in vulnerable people. Foodborne Pathog Dis 2011;8(9):961-973.
13. Erkekoǧlu P, Sipahi H, Şahin G, Baydar T. A Hidden danger in infant formulas and baby foods: Enterobacter sakazakii contamination. FABAD J Pharm Sci 2009;34:153-165.
14. Lynch MF, Tauxe RV, Hedberg CW. The growing burden of foodborne outbreaks due to contaminated fresh produce: risks and opportunities. Epidemiol Infect 2009;37(3):307-315.
15. Anonymus. US Food and Drug Administration, 2002. Isolation and enumeration of Enterobacter sakazakii from dehydrated powdered infant formula. Available at: http://www.cfsan.fda.gov/comm/mmesakaz.html. Access date: Sep 19, 2003.
16. Anonymus. U. Food and Drug Administration, 2002. Questions and answers on method for Esakazakii in powdered infant formula. Available at: http://www.cfsan.fda.gov/~comm/mmesakqa.Html Access date: Oct 10, 2003.
17. Clinical and Laboratory Standards Institute (CLSI): Standards for antimicrobial. susceptibility testing; Twenty-first international supplement. M100-S21. 2011;31:1.
18. CDC report. 2009/ 58 (RR04); 1-198. Available at: www.cdc.gov/mmwr/preview/mmwrhtml/rr5804a 1.htm. Access date: Mar 24, 2010.
19. Walensky RP, Paltiel AD, Losina E, et al. The survival benefits of AIDS treatment in the United States. J Infect Dis 2006;194(1):11-19.
20. Couto RC, Carvalho EA, Pedrosa TM, et al. A 10-year prospective surveillance of nosocomial infections in neonatal intensive care units. Am J Infect Control 2007;35(3):183-189.
21. Stover BH, Shulman ST, Bratcher DF, et al. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001;29(3):152-157.
22. Urrea M, Iriondo M, Thio M, et al. A prospective incidence study of nosocomial infections in a neonatal care unit. Am J Infect Control 2003;31(8): 505-507.
23. Wilson CB, Lewis DB, English K. Immunity in the neonate. Semin Pediatr Infect Dis 1999;10:83-90.